Excellent work NuGilead on the timelines! Also keep in mind there are over 4x the number of patients in cd12 vs cd10, which means much more data to tally, analyze & report than cd10. I remember Dr. BP mentioning there are tens of thousands bits of data, and that was just for 85 patients! Many keep saying mortality is easy to compute, and yes, relatively speaking it is, but the company will keep that in-house until the minimum amount of analysis has been done to release a top-line report.